COMMUNIQUÉS West-GlobeNewswire

XORTX Provides Overview and Announces $5 Million Financing to Advance Clinical Trials
29/04/2019
Pivotal Registration Clinical Study with XRx-008 and Phase 2b Clinical Study withTMX-049 Planned in 2020 CALGARY, Alberta, April 29, 2019 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE: [...]
TCR2 Therapeutics Announces First Quarter 2019 Earnings Conference Call and Webcast
29/04/2019
Earnings to be released after market close on Monday, May 13, 2019 CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- TCR 2 Therapeutics Inc. (TCR 2 ) (Nasdaq: TCRR), a clinical-stage immunotherapy company developing [...]
Avadel Pharmaceuticals to Report First Quarter 2019 Financial Results
29/04/2019
DUBLIN, Ireland, April 29, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218 for sleep disorders, today announced that it will host a conference call and live [...]
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
29/04/2019
WALTHAM, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) today announced that it has commenced an underwritten public offering of $175,000,000 in shares of its common stock. In addition, [...]
Novan Secures Up to $35 Million in Non-Dilutive Funding
29/04/2019
$25 million provided immediately in exchange for participation in future potential cash flows Additional $10 million available upon achieving success in molluscum Phase 3 top line results Pipeline Priority: initiation [...]
Precision BioSciences Reports First Quarter 2019 Financial Results
29/04/2019
DURHAM, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences, a genome editing company dedicated to improving life (Nasdaq: DTIL) (“Precision”) through the application of its proprietary ARCUS genome editing [...]
Alimera Sciences Announces First Quarter 2019 Financial Results and Provides Corporate Overview
29/04/2019
First Quarter and Recent Company Highlights: Global revenue up 34% versus Q1 2018 Regulatory approval obtained for ILUVIEN ® in 17 EU countries for the treatment of Non-Infectious Posterior Uveitis Samer Kaba, M.D. [...]
Otonomy to Report First Quarter 2019 Financial Results and Provide Corporate Update
29/04/2019
Webcast and Conference Call to be Held at 4:30 p.m. EDT on May 6, 2019 SAN DIEGO, April 29, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative [...]
Silk Road Medical to Report First Quarter 2019 Financial Results on May 8, 2019
29/04/2019
SUNNYVALE, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results [...]
SI-BONE to Present at the Bank of America Merrill Lynch 2019 Health Care Conference
29/04/2019
SANTA CLARA, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that management [...]
Sunesis Pharmaceuticals Announces Refinancing of Existing Loan with $5.5 Million Loan from Silicon Valley Bank
29/04/2019
SOUTH SAN FRANCISCO, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it has entered into a $5.5 million loan agreement with Silicon Valley Bank . The new [...]
Precision Optics Corporation, Inc. Announces Receipt of $2.2 Million Order For Custom Designed Cardiovascular Endoscope
29/04/2019
GARDNER, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) today announced that it has received a follow-on order totaling $2,216,000 from CardioFocus, Inc. for the manufacture [...]
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2019 Financial Results
29/04/2019
-Enrollment ongoing in Phase 1/2 clinical trials of CTX001™ for patients with severe hemoglobinopathies- -IND and CTA approved for CTX110™, wholly-owned allogeneic CAR-T cell therapy targeting CD19+ malignancies- -On [...]
G1 Therapeutics Announces Positive Feedback from Trilaciclib End-of-Phase 2 Meeting with FDA; Expects to File NDA in 2020
29/04/2019
Research Triangle Park, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today provided a regulatory update on trilaciclib, a first-in-class [...]
Mustang Bio Announces Proposed Public Offering of Common Stock
29/04/2019
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
SunGen Pharma Receives its Fourth and Fifth ANDA Approvals from US FDA
29/04/2019
PRINCETON, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- SunGen Pharma, a privately held specialty pharmaceutical company which develops, contract manufactures, and sells pharmaceutical finished products, today announced it [...]
IRIDEX’s MicroPulse® Laser Technology Featured in Several Glaucoma and Retina Research Presentations at Major Ophthalmic Industry Conferences
29/04/2019
MOUNTAIN VIEW, Calif., April 29, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced [...]
Innovate Biopharmaceuticals Announces $8.7 Million Registered Direct Offering Priced At-the-Market
29/04/2019
RALEIGH, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) today announced that it has entered into securities purchase agreements with certain institutional investors providing [...]
Emendo Biotherapeutics Enters Into Licensing Option Agreement With Takeda for its OMNI Nuclease Program
29/04/2019
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Emendo Biotherapeutics Inc. today announced that the company signed a licensing option agreement with Takeda Pharmaceutical Company Limited. As part of the transaction, [...]

Pages